TrialLeukemia & lymphoma2011

Sunitinib in relapsed or refractory diffuse large B-cell lymphoma: a clinical and pharmacodynamic phase II multicenter study of the NCIC Clinical Trials Group.

Rena Buckstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.